Patent · US Active

Separation matrix

US10654887B2 · kind B2 · utility

11Cited by

77References

29Claims

0Family size

Assignee

GE Healthcare BioProcess R&D AB · SE

Inventors

Gustav Rodrigo · Uppsala, SE
Tomas Bjorkman · Uppsala, SE
Mats Ander · Uppsala, SE
Jesper Ulf Hansson · Uppsala, SE

Key dates

Filing date	Sep 30, 2016
Grant date	May 19, 2020
Priority date	—
Expiry date	Apr 19, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K17/10
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The invention relates to a separation matrix comprising at least 11 mg/ml Fc-binding ligands covalently coupled to a porous support, wherein:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.